MHLU - Health Status Resource

Health-related Behaviours

Health-related Behaviours

Key Findings: 
  • In 2010, 62.1% of Middlesex-London women who had given birth reported having visited a health care provider to help plan for a healthy pregnancy. This represents a 1.7 fold increase compared to 2001 (Fig. 9.1).
  • About nine out of every 10 pregnant women in Middlesex-London reported having prenatal care from a health care provider during the first trimester (3 months) of their pregnancy. This did not appear to change significantly from 2001 to 2010 (Fig. 9.1).
  • In 2010, almost two-thirds of Middlesex-London women who had given birth reported taking a vitamin supplement containing folic acid within 12 months before getting pregnant (Fig. 9.1).
  • About one in five (19.6%) Middlesex-London females who gave birth in 2008 were estimated to have smoked at some point during their pregnancy, according to the BORN perinatal information system (data not shown). The rate for Middlesex-London is higher than for southwestern Ontario (18.6%) and Ontario (12.4). The data for Ontario in particular, however, is of lower quality due to missing responses (data not shown).
Interpretive Notes

The indicators of prenatal health behaviours presented in Figure 9.1 are based on self-reported survey data from the Rapid Risk Factor Surveillance System (RRFSS). These data are based on responses to random digit-dialled telephone interviews of Middlesex-London women ages 18 to 49 who have had a baby within the past five years. The questions asked verbatim are as follows:

  • “Prior to becoming pregnant (with your LAST child), did you visit a health care provider to help you plan for a healthy pregnancy and baby?”
  • “Did you take a vitamin supplement containing folic acid BEFORE you became pregnant (for your lastpregnancy)?”
  • “How many months were you pregnant with your LAST child, when you first received prenatal care from your family doctor, GP, or other health care provider?”
Ontario Public Health Standard: 

Population Health Assessment and Surveillance Protocol - Section 1